Alan Clyde Hayes Savage

Alan Clyde Hayes Savage discloses dealings in Epicore BioNetworks Inc. to SEDI. We count 8 filings; the first trade dates from 7 January 2009 and the latest from 22 December 2017.

In open-market terms, that means 3 purchases worth €3,644 on one side and 1 sale worth €16k on the other. Sales outweigh purchases by €13k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2017 alone, the filings show no purchases and 1 sale.

In size, the median ticket on the buying side is €1,500. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

On 27 December 2017 came the latest disclosure, a transaction for €3.2M in Epicore BioNetworks Inc. The last insider purchase was made public on 5 December 2016, 3,610 days ago. Filings reach the SEDI feed a median of 1 day after the trade. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.